ArticleJournal of gastrointestinal cancer2026

Relative Dose Intensity and Clinical Outcomes of Using Trifluridine/Tipiracil with or without Bevacizumab in Patients Aged ≥ 75 Years with Advanced or Recurrent Colorectal Cancer: a Single-Center Retrospective Study.

Aiko Tomiuchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.